您的位置: 首页 > 农业专利 > 详情页

Angiotensin II receptor antagonist for the prevention or treatment of systemic diseases in cats
专利权人:
Boehringer Ingelheim Vetmedica GmbH
发明人:
Albrecht, Balazs,Anke, Sven,Kley, Saskia,Lehner, Stefan Johannes,Stark, Marcus,Traas, Anne Michelle,Zimmering, Tanja Margrit
申请号:
AU2018295387
公开号:
AU2018295387A1
申请日:
2018.07.05
申请国别(地区):
AU
年份:
2020
代理人:
摘要:
A method is described for the prophylaxis or treatment of hypertension in a cat in need of such treatment. The method includes administration of a therapeutically effective amount of angiotensin II receptor 1 (AT-1) antagonist (sartan) to the cat, where the therapeutically effective amount of the sartan is administered in a daily dosage amount that is varied over a treatment period, the daily dosage amount of the sartan for a first period of time during the treatment period is 1.0 to 5.0 mg/kg of body weight, and the daily dosage amount of the sartan is decreased for a second period of time subsequent the first period of time during the treatment period.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充